title: Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
abstract: Periventricular leukomalacia (PVL) is the predominant pathology in premature infants, characterized by prominent cerebral white matter injury, and commonly caused by hypoxia-ischemia and inflammation. Activated microglia trigger white matter damage and play a major role in the development of PVL. Erythropoietin (EPO) and its derivative carbamylated erythropoietin (CEPO) have been shown to be neuroprotective in several brain disease models. Here we investigated whether EPO and CEPO could provide protection in mouse models of PVL induced by hypoxia-ischemia or hypoxia-ischemia-inflammation. We administered EPO or CEPO to mice with PVL, and found that both EPO and CEPO treatments decreased microglia activation, oligodendrocyte damage and myelin depletion. We also noted improved performance in neurological function assays. Inhibited disease progression in PVL mice by EPO or CEPO treatment was associated with decreased poly-(ADP-ribose) polymerase-1 (PARP-1) activity. PARP-1 activity was increased dramatically in activated microglia in untreated mice with PVL. Furthermore, we demonstrated that the neuroprotective properties of EPO and CEPO were diminished after PARP-1 gene depletion. The therapeutic doses of EPO and CEPO used in this study did not interfere with normal oligodendrocyte maturation and myelination. Together, our data demonstrate that EPO and CEPO are neuroprotective in cerebral white matter injury via a novel microglial PARP-1 dependent mechanism, and hold promise as a future treatment for PVL and other hypoxic-ischemic/inflammatory white matter diseases.
authors: Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, CA 95616, USA.
authors: Wei
authors: W
authors: Liu
authors: Yan
authors: Y
authors: Shen
authors: Jennifer M
authors: JM
authors: Plane
authors: David E
authors: DE
authors: Pleasure
authors: Wenbin
authors: W
authors: Deng
references: Intern Med. 2003 Feb;42(2):142-9
references: 12636232
references: Brain Behav Immun. 2003 Feb;17(1):13-9
references: 12615045
references: Science. 2002 Jul 12;297(5579):259-63
references: 12114629
references: Arch Neurol. 2008 Oct;65(10):1291-5
references: 18852342
references: J Exp Med. 2003 Sep 15;198(6):971-5
references: 12975460
references: FASEB J. 2001 Jun;15(8):1460-2
references: 11387257
references: Stroke. 2007 Oct;38(10):2795-803
references: 17702962
references: J Cereb Blood Flow Metab. 2007 Mar;27(3):552-63
references: 16835629
references: J Neurosurg. 2007 Aug;107(2):392-7
references: 17695395
references: Eur J Neurosci. 1996 Jun;8(6):1106-16
references: 8752580
references: Lancet Neurol. 2009 Jan;8(1):110-24
references: 19081519
references: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1103-8
references: 15279798
references: J Oncol Pharm Pract. 2005 Dec;11(4):145-9
references: 16595066
references: Pediatrics. 2008 Apr;121(4):788-801
references: 18381544
references: Neurobiol Dis. 2003 Dec;14(3):303-17
references: 14678748
references: Trends Neurosci. 1996 Aug;19(8):312-8
references: 8843599
references: J Neuropathol Exp Neurol. 2003 Mar;62(3):228-36
references: 12638727
references: J Neuropathol Exp Neurol. 2010 Mar;69(3):306-19
references: 20142760
references: Stroke. 1995 Apr;26(4):627-34; discussion 635
references: 7709410
references: Dev Neurosci. 2009;31(5):403-11
references: 19672069
references: Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F153-61
references: 18296574
references: J Neurosci Res. 2005 Apr 15;80(2):226-34
references: 15765524
references: Lancet. 2007 Jan 6;369(9555):43-50
references: 17208641
references: Pediatr Res. 2001 Nov;50(5):553-62
references: 11641446
references: J Immunol. 2005 Feb 15;174(4):2288-96
references: 15699164
references: Nat Struct Biol. 2002 Sep;9(9):680-4
references: 12198487
references: Drug News Perspect. 2007 Jun;20(5):315-20
references: 17878959
references: J Comp Neurol. 2006 Jul 10;497(2):199-208
references: 16705680
references: Exp Neurol. 2007 Mar;204(1):106-17
references: 17157835
references: Ment Retard Dev Disabil Res Rev. 2002;8(1):46-50
references: 11921386
references: J Neurosci Res. 2004 Jun 15;76(6):834-45
references: 15160395
references: Brain Res Rev. 2008 Nov;59(1):22-33
references: 18514916
references: Ment Retard Dev Disabil Res Rev. 2002;8(1):3-13
references: 11921380
references: Pediatrics. 2005 Jul;116(1):221-5
references: 15995055
references: J Neurochem. 2003 Apr;85(2):306-17
references: 12675907
references: J Neurosci. 2004 May 5;24(18):4412-20
references: 15128855
references: J Neurochem. 2010 May;113(4):1012-22
references: 20236222
references: Stroke. 2004 Jul;35(7):1732-7
references: 15178821
references: J Immunol. 2004 Sep 15;173(6):3916-24
references: 15356140
references: J Exp Med. 1999 Feb 15;189(4):615-25
references: 9989976
references: Nat Rev Neurol. 2010 Jun;6(6):328-36
references: 20479779
references: Nature. 1999 Feb 4;397(6718):441-6
references: 9989411
references: J Neurosci. 2000 Dec 15;20(24):9235-41
references: 11125001
references: Nat Cell Biol. 2001 Dec;3(12):1035-42
references: 11781564
references: Pediatrics. 2003 Jul;112(1 Pt 1):176-80
references: 12837883
references: Pharmacol Rev. 2002 Sep;54(3):375-429
references: 12223530
references: J Biol Chem. 2004 Oct 8;279(41):42774-86
references: 15302869
references: Dev Neurosci. 2007;29(4-5):321-30
references: 17762200
references: Ann Neurol. 2008 Apr;63(4):520-30
references: 18393269
references: FEBS J. 2005 Sep;272(18):4576-89
references: 16156780
references: Trends Biochem Sci. 2001 Mar;26(3):174-9
references: 11246023
references: Neurosci Lett. 2004 Apr 8;359(1-2):124-6
references: 15050726
references: Brain. 2010 Mar;133(Pt 3):822-34
references: 20157013
references: Nat Rev Drug Discov. 2005 May;4(5):421-40
references: 15864271
references: Stroke. 2010 May;41(5):1032-7
references: 20360553
references: Science. 2004 Jul 9;305(5681):239-42
references: 15247477
references: Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10526-31
references: 10984541
references: Br J Pharmacol. 2007 Aug;151(8):1377-84
references: 17603558
references: Stroke. 2007 Feb;38(2 Suppl):632-6
references: 17261705
references: Eur J Neurosci. 1996 Apr;8(4):666-76
references: 9081618
references: Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9936-41
references: 15998743
references: Brain Res. 2002 Feb 1;926(1-2):108-17
references: 11814412
references: Clin Neurol Neurosurg. 2007 Oct;109(8):639-44
references: 17624659
references: J Pharmacol Exp Ther. 2006 Apr;317(1):109-16
references: 16357210
references: Curr Opin Pediatr. 2010 Apr;22(2):139-45
references: 20090525
references: Science. 1998 Dec 11;282(5396):2085-8
references: 9851930
references: J Neurotrauma. 2010 Jun;27(6):1069-79
references: 20380552